SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-004267
Filing Date
2020-12-11
Accepted
2020-12-11 16:47:33
Documents
62
Period of Report
2020-10-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT pharmacyte_10q-103120.htm 10-Q 488013
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER pharmacyte_ex3101.htm EX-31.1 9072
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER pharmacyte_ex3102.htm EX-31.2 9052
4 CERTIFICATION pharmacyte_ex3201.htm EX-32.1 4399
5 CERTIFICATION pharmacyte_ex3202.htm EX-32.2 4846
  Complete submission text file 0001683168-20-004267.txt   3341971

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pmcb-20201031.xml EX-101.INS 666068
7 XBRL SCHEMA FILE pmcb-20201031.xsd EX-101.SCH 37418
8 XBRL CALCULATION FILE pmcb-20201031_cal.xml EX-101.CAL 42345
9 XBRL DEFINITION FILE pmcb-20201031_def.xml EX-101.DEF 161059
10 XBRL LABEL FILE pmcb-20201031_lab.xml EX-101.LAB 255502
11 XBRL PRESENTATION FILE pmcb-20201031_pre.xml EX-101.PRE 234694
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-68008 | Film No.: 201383997
SIC: 2836 Biological Products, (No Diagnostic Substances)